Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Pancreatic Neoplasms"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Digestive+System+Neoplasms%22&type=Subject&filter%5B%5D=topic_facet%3A%22Pancreatic+Neoplasms%22
/vufind/Search/Results?lookfor=%22Digestive+System+Neoplasms%22&type=Subject&filter%5B%5D=topic_facet%3A%22Pancreatic+Neoplasms%22
Search /vufind/Search2/Results?lookfor=%22Digestive+System+Neoplasms%22&type=Subject&filter%5B%5D=topic_facet%3A%22Pancreatic+Neoplasms%22
PubPharm (30)
1
Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer : Pilot Study of Oral Cryotherapy vs. Oral Cryotherapy Plus Acupuncture and Acupressure to Decrease Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy for GI Cancers
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors : A Phase I/IIa First-in-Human Study of [212Pb]VMT-α-NET Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
A Study Evaluating Different Doses of BI 765049 When Given Alone and When Given With Ezabenlimab to Patients With Advanced Solid Tumors Expressing the Protein B7-H6 on the Cell Surface : A First-in-human Phase I, Non-randomized, Open-label, Multi-center Dose Escalation Trial of BI 765049 and BI 765049 + BI 754091 Administered by Parental Administration(s) in Patients With Malignant Solid Tumors Expressing B7-H6
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2 : A Phase 1 Dose Escalation and Expansion Study of EO-3021, an Anti-claudin 18.2 (CLDN18.2) Antibody Drug Conjugate, in Patients With Solid Tumors Likely to Express CLDN18.2
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2 : A Phase 1 Dose Escalation and Expansion Study of EO-3021, an Anti-claudin 18.2 (CLDN18.2) Antibody Drug Conjugate, in Patients With Solid Tumors Likely to Express CLDN18.2
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events : There Is No Place Like Home- A Pragmatic Effectiveness Trial of Technology-Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma : A Phase 2A, Dose-Finding Study of Ad5.F35-hGCC-PADRE Vaccine in Adults With Gastrointestinal Adenocarcinomas at Risk of Relapse Post Definitive Surgery and Standard Therapy
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
A Study Evaluating Different Doses of BI 765049 When Given Alone and When Given With Ezabenlimab to Patients With Advanced Solid Tumors Having the B7-H6 Marker : A First-in-human Phase I, Non-randomized, Open-label, Multi-center Dose Escalation Trial of BI 765049 and BI 765049 + BI 754091 Administered by Repeated Intravenous Infusions in Patients With Malignant Solid Tumors Expressing B7-H6
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
A Study to Find a Safe and Effective Dose of BI 905711 in Patients With Advanced Gastrointestinal Cancer : A First-in-human Phase Ia/b, Open Label, Multicentre, Dose Escalation Study of BI 905711 in Patients With Advanced Gastrointestinal Cancers
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer : A Phase I/II Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan (GAX-CI) in Combination in Metastatic Pancreatic Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Pancreatic Neoplasms
Medienart
30
Aufsätze
30
E-Artikel
30
E-Ressourcen
Zeitschriftentitel
30
ClinicalTrials.gov
Thema
30
610
30
Digestive System Neoplasms
30
Gastrointestinal Neoplasms
Pancreatic Neoplasms
24
Study Type: Interventional
22
Neoplasms
12
Recruitment Status: Recruiting
11
Stomach Neoplasms
9
Colorectal Neoplasms
8
Phase: Phase 1
8
Recruitment Status: Completed
7
Digestive System Diseases
7
Gastrointestinal Diseases
7
Neuroendocrine Tumors
6
Endocrine Gland Neoplasms
6
Neoplasms by Site
6
Pancreatic Diseases
6
Phase: Phase 2
6
Study Type: Observational
5
Cholangiocarcinoma
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
22
2020-
7
2010-2019
1
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
30
Englisch
Haven't found what you're looking for?
Wird geladen...